Results 1 to 10 of about 58,637 (158)

A case of hand-foot syndrome with olaparib. [PDF]

Pan Afr Med J, 2022
Hand-foot syndrome or palmar-plantar erythrodysesthesia is an adverse cutaneous reaction to chemotherapy, mainly associated with capecitabine, doxorubicin, sorafenib, sunitinib, and vemurafenib. Skin reaction is characterized by the abrupt onset of dysesthesia, erythema, swelling, and fine desquamation of the hands and feet.
da Costa REAR, Valença RJV.
europepmc   +4 more sources

Do you know this syndrome? Hand-foot syndrome [PDF]

Anais Brasileiros de Dermatologia, 2017
Hand-foot syndrome is a common cutaneous adverse effect associated with certain systemic chemotherapy drugs. It is characterized by erythema, edema, and burning sensation, especially over palmoplantar surfaces.
Cintia Santos Braghiroli, Rodrigo Ieiri, Juliana Polizel Ocanha, Rafael Bispo Paschoalini, Hélio Amante Miot   +4 more
doaj   +6 more sources

An unusual and severe case of paclitaxel‐induced hand‐foot syndrome [PDF]

Clinical Case Reports, 2021
Although paclitaxel is known to cause mild skin toxicity, it may induce severe HFS requiring drug withdrawal. Patients with high disease burden might receive prolonged paclitaxel chemotherapy. Hence, a grade 2 toxicity would better indicate withdrawal of
Ichrak Ben Abdallah, Sonia Ben Nasr, Aref Zribi, Jihene Ayarai, Sana Fendri, Balti Mehdi, Haddaoui Abderrazek   +6 more
doaj   +2 more sources

Hand–Foot syndrome to sorafenib: A case report

Clinical Dermatology Review, 2022
Sherin Dominic, Vijay Venkatraj Aithal
doaj   +2 more sources

Hand-foot syndrome due to capecitabine

Indian Journal of Dermatology, 2008
Surjushe Amar, Vasani Resham, Medhekar Sudhir, Thakre Minal, Saple D   +4 more
doaj   +5 more sources

Dupilumab for management of capecitabine-induced hand-foot syndrome [PDF]

JAAD Case Reports
Ian Nykaza, BS, Rachel Sanford, MD, Allison Gordon, MD   +2 more
doaj   +2 more sources

HAND-FOOT-UTERUS SYNDROME [PDF]

The Lancet, 1969
Peer Reviewed ; http://deepblue.lib.umich.edu/bitstream/2027.42/32999/1/0000383 ...
Stern, Aaron M., Gall, Jr. , J. C., Perry, Burton L., Stimson, Cyrus W.   +3 more
openaire   +4 more sources

Drug-Induced Hand-Foot Syndrome in Cancer Patients Receiving Capecitabine in A Tertiary Care Hospital

Pakistan Armed Forces Medical Journal, 2023
Objective: To determine the frequency of hand-foot syndrome and associated factors among patients receiving Capecitabine for the management of cancer in a tertiary care setting. Study Design: Cross-sectional study.
Ibtisam Idrees, Riaz Ahmad, Muhammad Umair, Anum Zargham, Mir Jalal-ud- Din, Tahir Manoor Lone   +5 more
doaj   +1 more source

Adverse dermatoneurological events and impacts on daily activities of patients with gastrointestinal neoplasms undergoing chemotherapy [PDF]

Revista Brasileira de Enfermagem, 2023
Objective: to associate the presence and grading of adverse dermatoneurological events (peripheral neuropathy and hand-foot syndrome) and the interference in the activities of daily living of patients with gastrointestinal neoplasms undergoing systemic ...
Rafaela Moreira da Silva Canille, Maria Helena Pinto, Katia Jaira Galisteu, Rildo César Czorny, Luana Gaino Bertolazzi, Tamara Veiga Faria   +5 more
doaj   +1 more source

The Efficacy and Safety of Captopril in Preventing Capecitabine-induced Hand-foot Syndrome: A Randomized Double-blinded Placebo-controlled Clinical Trial [PDF]

Middle East Journal of Cancer, 2023
Background: Hand-foot syndrome (HFS) is a prevalent skin reaction to cytotoxic systemic therapy, mainly Capecitabine. The present study aimed to determine etiologies of HFS in addition to its prevention in colorectal cancer patients with Capecitabine ...
Mahnaz Roayaei, Nooshin Nazeminezhad, Nadia Najafizade, Mehran Sharifi   +3 more
doaj   +1 more source